Robert H.Lurie Comprehensive Cancer Center
Chicago, Illinois 61612
1 studies enrolling now · 18 studies all time
What they study most
Acute Myeloid Leukemia, Acute Myeloid Leukemia (AML), Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) Mutation, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Acute Myeloid Leukemia in Remission, Advanced Adult Hepatocellular Carcinoma, Advanced BRAF Mutant Melanoma
Studies at this site
- Feasibility and Acceptibility of a Multi-site Trial of Time Restircted Eating During Chemotheraply for Breast Cancer. — Recruiting now
- A Study of ASP2215 (Gilteritinib) by Itself, ASP2215 Combined With Azacitidine or Azacitidine by Itself to Treat Adult Patients Who Have Recently Been Diagnosed With Acute Myeloid Leukemia With a FLT3 Gene Mutation and Who Cannot Receive Standard Chemotherapy — Completed
- A Study of Gilteritinib, Venetoclax and Azacitidine as a Combined Treatment for People Newly Diagnosed With Acute Myeloid Leukemia — Running, not enrolling
- Sorafenib Tosylate and Pembrolizumab in Treating Patients With Advanced or Metastatic Liver Cancer — Completed
- A Safety and Efficacy Study in Patients With Gastric Cancer — Completed
- A Phase 2 Study Comparing 2 Intermittent Dosing Schedules of Duvelisib in Participants With Indolent Non-Hodgkin Lymphoma — Completed
- QUILT-3.009: Patients With Stage III (IIIB) or Stage (IV) Merkel Cell Carcinoma (MCC) — Stopped early
- A Randomized Phase 2 Study of Cemiplimab ± ISA101b in HPV16-Positive OPC — Status unconfirmed
- Naloxone Hydrochloride Study for Relief of Pruritus in Patients With MF or SS Forms of CTCL — Stopped early
- Dabrafenib, Trametinib and Hydroxychloroquine in Patients With Advanced BRAF Mutant Melanoma — Completed
- Phase II Combination of Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma — Completed
- Plan to Thrive: Extending Cancer Survivorship Care Beyond the Clinic — Completed
- A Study of ONTAK and CHOP in Newly Diagnosed, Peripheral T-Cell Lymphoma — Completed
- A Dose Escalation Study of Lenalidomide in Relapsed or Refractory B-cell Chronic Lymphocytic Leukemia — Completed
- Trial of CPX-351 in Newly Diagnosed Elderly AML Patients — Completed
- Low-Dose Total-Body Irradiation and Fludarabine Phosphate Followed by Unrelated Donor Stem Cell Transplant in Treating Patients With Fanconi Anemia — Completed
- Photodynamic Therapy Using Aminolevulinic Acid in Treating Patients With Oral Leukoplakia — Stopped early
- A Study of Motexafin Gadolinium for the Treatment of Relapsed or Refractory Multiple Myeloma — Completed